$NRXS
Neuraxis, Inc.
XASE•Health Care•Electromedical & Electrotherapeutic Apparatus
Why is NRXS down today? It is at $6.15 (-1.91%), and our scanner flagged it 12 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NRXS spikes, and full due diligence on NRXS — key stats, earnings, dilution and insider activity. Free.
Get free $NRXS alerts the moment volume spikes
Our scanner flagged $NRXS 12 times in the last 30 days. Create a free account to track $NRXS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $6.15
- Change today
- -1.91%
- Previous close
- $6.27
- 52-week range
- $2.21 – $9.33
- Market cap
- $77M
- Institutional own.
- 22.91%
- Total held
- 43.5%
- Tradeable float
- 7.1M 56% of shares · after 21% insiders + 23% institutions
- Short interest
- 418K ▼ -11% vs prior · as of 2026-07-31
- Short % of float
- 5.9%
- Days to cover
- 5.0d
- Avg daily volume
- 258K
- Sector
- Health Care
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Exchange
- XASE
- 5mthin
- 250x
- 15mthin
- 250x
- 1hthin
- 225x
- 1D
- --
Get free NRXS + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $NRXS down today?
Here is the latest on NRXS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NRXS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystExecutive / Board Change · Other Material Event, from the latest SEC filing. Read it →Insiders
Insiders buying4 open-market buys6 buys, 0 sells last 3 months (18/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Aharon Gil Director | Acquired (grant/award) | +44K 0.3% of company | added 100% | 80K | $276K at $6.28 | Aug 13, 26 |
Ferge Kristin A Director | Acquired (grant/award) | +31K 0.2% of company | added 87% | 67K | $196K at $6.28 | Aug 13, 26 |
Keyser Jane Elizabeth Director | Acquired (grant/award) | +26K 0.2% of company | added 56% | 72K | $164K at $6.28 | Aug 13, 26 |
Watkins Bradley Mitchell Director | Acquired (grant/award) | +26K 0.2% of company | added 56% | 72K | $164K at $6.28 | Aug 13, 26 |
Aharon Gil Director | Acquired (grant/award) | +2K 0.02% of company | added 6.6% | 36K | n/a | Jul 29, 26 |
Aharon Gil Director | Acquired (grant/award) | +40K 0.3% of company | added 7.9% | 548K | n/a | Jul 29, 26 |
Aharon Gil Director | Acquired (grant/award) | +12K 0.10% of company | added 57% | 34K | n/a | Apr 28, 26 |
Aharon Gil Director | Acquired (grant/award) | +222K 1.8% of company | added 78% | 508K | n/a | Apr 28, 26 |
Carrico Brian Allen Officer | Bought (open market) | +8K 0.06% of company | added 2.4% | 348K | $16K at $1.96 | Apr 1, 26 |
Carrico Thomas Joeseph Officer | Bought (open market) | +667 | added 0.2% | 332K | $1K at $1.96 | Apr 1, 26 |
Henrichs Timothy Robert Officer | Bought (open market) | +8K 0.06% of company | n/a | 8K | $15K at $1.96 | Apr 1, 26 |
Hannasch Brian Beneficial Owner (10%) | Bought (open market) | +40K 0.3% of company | added 3.4% | 1.21M | $197K at $4.92 | Feb 12, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $NRXS runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 1,923,194 new shares
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$NRXS Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$NRXS Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to NRXS
Comparable names in electromedical & electrotherapeutic apparatus, closest in size first.
NRXS stock FAQ
Why is $NRXS down today?
Here is the latest on NRXS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NRXS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the NRXS stock price today?
NRXS last traded at $6.15, down 1.91% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live NRXS alerts?
The NRXS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NRXS 12 times in the last 30 days.
What exchange is NRXS on?
NRXS (Neuraxis, Inc.) trades on XASE, with a market cap of about $77M in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector.
Is NRXS good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NRXS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.